Ventricular Remodeling: Clinical Trials

4 trials for Ventricular Remodeling, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 24Completed 4

Follow Ventricular Remodeling: new trials by email Literature Review of Ventricular Remodeling trials Research Report on Ventricular Remodeling

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Empagliflozin 10 vs 25 mg on LV Remodeling in Diabetic Patients With Anterior STEMI With Reduced LVEF
Empagliflozin 10 MG [Jardiance], empagliflozin (Jardiance) 25 mg - Diabete Mellitus, Heart Failure
Phase 2CompletedAin Shams University2002023-07-122025-09-12
COlchicine for Left VEntricular Remodeling Treatment in Acute Myocardial Infarction
Colchicine group (experimental arm), Placebo group (control arm) - Myocardial Infarction
Phase 2CompletedHospices Civils de Lyon1942018-07-232025-08-01
Tetracycline (Doxycycline) and Post Myocardial Infarction Remodeling
Doxycycline, Current medical therapy for AMI - Myocardial Infarction, Left Ventricular Remodeling
Phase 2CompletedCareggi Hospital1102007-05-012012-09-25
REVEAL: Reduction of Infarct Expansion and Ventricular Remodeling With Erythropoietin After Large Myocardial Infarction
Epoetin alfa - Acute ST Elevation Myocardial Infarction
Phase 2CompletedNational Institute on Aging (NIA)2232005-09-012017-05-09

Narrower conditions

Myocardial Infarction (2)  ·  Diabetes Mellitus (1)  ·  Heart Failure (1)  ·  Inflammation (1)  ·  ST Elevation Myocardial Infarction (1)

Broader conditions

Pathological Conditions, Anatomical (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Cardiovascular Diseases (3)  ·  Heart Diseases (3)  ·  Infarction (2)  ·  Ischemia (2)  ·  Myocardial Ischemia (2)  ·  Necrosis (2)  ·  Pathologic Processes (2)  ·  Vascular Diseases (2)  ·  Endocrine System Diseases (1)  ·  Glucose Metabolism Disorders (1)  ·  Metabolic Diseases (1)  ·  Nutritional and Metabolic Diseases (1)

Interventions

Doxycycline (1)  ·  Epoetin Alfa (1)  ·  empagliflozin (1)

Sponsors

Ain Shams University (1)  ·  Careggi Hospital (1)  ·  Hospices Civils de Lyon (1)  ·  National Institute on Aging (NIA) (1)

Countries

Egypt (1)  ·  France (1)  ·  United States (1)

Top investigators

Alberto Santini, MD (1)  ·  David Antoniucci, MD (1)  ·  Edward G Lakatta, M.D. (1)  ·  Emilio V Dovellini, MD (1)  ·  Giampaolo Cerisano, MD (1)  ·  Nazario Carrabba, MD (1)  ·  Paolo D Pucci, MD (1)  ·  Piergiovanni Buonamici, MD (1)  ·  Renato Valenti, MD (1)  ·  Umberto Signorini, MD (1)  ·  Zainab A. Fahmy, Professor of Cardiology (1)

Results publications

PMID 21095264, PMID 21558517, PMID 24104875, PMID 34420373

NIH funding

2017 (1)